Peak6 Investments LLC Seagen Inc. Call Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $4.79 Million - $5.4 Million	25,000 New	25,000 $5.3 Million
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $995,202 - $1.58 Million	7,800 New	7,800 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $662,823 - $882,539	-4,900 Reduced 32.89%	10,000 $1.37 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $1.62 Million - $2.67 Million	14,900 New	14,900 $2.64 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $883,189 - $1.05 Million	-6,200 Closed	0 $0

Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $1.53 Million - $1.82 Million	-11,300 Reduced 64.57%	6,200 $979,000
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $26.7 Million - $37 Million	-193,900 Reduced 91.72%	17,500 $2.43 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $34.8 Million - $44.8 Million	211,400 New	211,400 $37 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.